SEARCH

SEARCH BY CITATION

References

  • Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R. and Begley D. J. (2010) Structure and function of the blood–brain barrier. Neurobiol. Dis. 37, 1325.
  • Aquilante C. L., Letrent S. P., Pollack G. M. and Brouwer K. L. R. (1999) Increased brain P-glycoprotein in morphine tolerant rats. Life Sci. 66, PL-47PL-51.
  • Bauer B., Hartz A. M. S., Fricker G. and Miller D. S. (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood–brain barrier. Mol. Pharmacol. 66, 413419.
  • Bauer B., Yang X., Hartz A. M. S., Olson E. R., Zhao R., Kalvass J. C., Pollack G. M. and Miller D. S. (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through p-glycoprotein up-regulation. Mol. Pharmacol. 70, 12121219.
  • Bauer B., Hartz A. M. S., Lucking J. R., Yang X., Pollack G. M. and Miller D. S. (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTπ, at the blood-brain barrier. J. Cereb. Blood Flow Metabol. 28, 12221234.
  • Bendayan R., Lee G. and Bendayan M. (2002) Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc. Res. Tech. 57, 365380.
  • Bertrand-Thiebault C., Masson C., Siest G., Batt A. M. and Visvikis-Siest S. (2007) Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line. J. Cardiovasc. Pharmacol. 49, 306315.
  • Burk O., Arnold K. A., Geick A., Tegude H. and Eichelbaum M. (2005) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386, 503513.
  • Chang T. K. H., Bandiera S. M. and Chen J. (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: Interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab. Dispos. 31, 710.
  • Dauchy S., Dutheil F., Weaver R. J., Chassoux F., Daumas-Duport C., Couraud P. O., Scherrmann J. M., De Waziers I. and Decleves X. (2008) ABC transporters, cytochromes P450 and their main transcription factors: Expression at the human blood-brain barrier. J. Neurochem. 107, 15181528.
  • Dauchy S., Miller F., Couraud P. O., Weaver R. J., Weksler B., Romero I. A., Scherrmann J. M., De Waziers I. and Declèves X. (2009) Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol. 77, 897909.
  • Dussault I., Lin M., Hollister K., Wang E. H., Synold T. W. and Forman B. M. (2001) Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J. Biol. Chem. 276, 3330933312.
  • Geick A., Eichelbaum M. and Burk O. (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276, 1458114587.
  • Healan-Greenberg C., Waring J. F., Kempf D. J., Blomme E. A. G., Tirona R. G. and Kim R. B. (2008) A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab. Dispos. 36, 500507.
  • Hennessy M., Kelleher D., Spiers J. P., Barry M., Kavanagh P., Back O., Mulcahy F. and Feely J. (2002) St. John’s Wort increases expression of P-glycoprotein: Implications for drug interactions. Br. J. Clin. Pharmacol. 53, 7582.
  • Hoque M. T. and Ishikawa F. (2001) Human chromatid cohesin component hRad21 Is phosphorylated in M phase and associated with metaphase centromeres. J. Biol. Chem. 276, 50595067.
  • Huang W., Zhang J., Wei P., Schrader W. T. and Moore D. D. (2004) Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol. Endocrinol. 18, 24022408.
  • Huang W., Sung Y. E., András I. E., Hennig B. and Toborek M. (2009) PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 23, 15961606.
  • Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K. and Negishi M. (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19, 63186322.
  • Kawana K., Ikuta T., Kobayashi Y., Gotoh O., Takeda K. and Kawajiri K. (2003) Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol. Pharmacol. 63, 524531.
  • Kim R. B., Fromm M. F., Wandel C., Leake B., Wood A. J. J., Roden D. M. and Wilkinson G. R. (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Investig. 101, 289294.
  • Kis O., Robillard K., Chan G. N. Y. and Bendayan R. (2010) The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol. Sci. 31, 2235.
  • Kobayashi K., Yamanaka Y., Iwazaki N., Nakajo I., Hosokawa M., Negishi M. and Chiba K. (2005) Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab. Dispos. 33, 924929.
  • Lamba J. K., Lamba V., Yasuda K., Lin Y. S., Assem M., Thompson E., Strom S. and Schuetz E. G. (2004) Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 311, 811821.
  • Li H., Chen T., Cottrell J. and Wang H. (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): A novel tool for screening hcar activators in human primary hepatocytes. Drug Metab. Dispos. 37, 10981106.
  • Maglich J. M., Parks D. J., Moore L. B. et al. (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278, 1727717283.
  • Meyer Zu Schwabedissen H. E., Tirona R. G., Yip C. S., Ho R. H. and Kim R. B. (2008) Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 68, 93389347.
  • Miki Y., Suzuki T., Tazawa C., Blumberg B. and Sasano H. (2005) Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol. Cell. Endocrinol. 231, 7585.
  • Miller D. S. (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246254.
  • Miller D. S., Nobmann S. N., Gutmann H., Toeroek M., Drewe J. and Fricker G. (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58, 13571367.
  • Moore L. B., Maglich J. M., McKee D. D., Wisely B., Willson T. M., Kliewer S. A., Lambert M. H. and Moore J. T. (2002) Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 16, 977986.
  • Nannelli A., Rossignolo F., Tolando R., Rossato P., Pellegatti M., Longo V. and Giovanni Gervasi P. (2010) Expression and distribution of CYP3A genes C YP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol. Cell. Biochem. 337, 133143.
  • Narang V. S., Fraga C., Kumar N., Shen J., Throm S., Stewart C. F. and Waters C. M. (2008) Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood–brain barrier. Am. J. Physiol. Cell Physiol. 295, C440C450.
  • Nishimura M., Naito S. and Yokoi T. (2004) Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab. Pharmacokinet. 19, 135149.
  • Ott M., Fricker G. and Bauer B. (2009) Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: Functional similarities between pig and human PXR. J. Pharmacol. Exp. Therap. 329, 141149.
  • Pardridge W. M. (2010) Biopharmaceutical drug targeting to the brain. J. Drug Target. 18, 157167.
  • Pascussi J. M., Drocourt L., Fabre J. M., Maurel P. and Vilarem M. J. (2000) Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 58, 361372.
  • Perloff M. D., VonMoltke L. L., Fahey J. M. and Greenblatt D. J. (2007) Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells. J. Pharm. Pharmacol. 59, 947953.
  • Ronaldson P. T., Lee G., Dallas S. and Bendayan R. (2004) Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. Pharmaceutical Res. 21, 811818.
  • Ronaldson P. T., Ashraf T. and Bendayan R. (2010) Regulation of multidrug resistance protein 1 by tumor necrosis factor α in cultured glial cells: Involvement of nuclear factor-κB and c-Jun N-terminal kinase signaling pathways. Mol. Pharmacol. 77, 644659.
  • Savkur R. S., Wu Y., Bramlett K. S. et al. (2003) Alternative splicing within the ligand binding domain of the human constitutive androstane receptor. Mol. Genetics Metabol. 80, 216226.
  • Schinkel A. H., Wagenaar E., Mol C. A. A. M. and Van Deemter L. (1996) P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Investig. 97, 25172524.
  • Squires E. J., Sueyoshi T. and Negishi M. (2004) Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J. Biol. Chem. 279, 4930749314.
  • Synold T. W., Dussault I. and Forman B. M. (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med., 7, 584590.
  • Timsit Y. E. and Negishi M. (2007) CAR and PXR: the xenobiotic-sensing receptors. Steroids 72, 231246.
  • Tsuji A., Terasaki T., Takabatake Y., Tenda Y., Tamai I., Yamashima T., Moritani S., Tsuruo T. and Yamashita J. (1992) P-Glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51, 14271437.
  • Urquhart B. L., Tirona R. G. and Kim R. B. (2007) Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566578.
  • Van Praag R. M. E., Weverling G. J., Portegies P. et al. (2000) Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS 14, 11871194.
  • Weksler B. B., Subileau E. A., Perrière N. et al. (2005) Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19, 18721874.
  • Woodland C., Huang T. T., Gryz E., Bendayan R. and Fawcett J. P. (2008) Expression, activity and regulation of CYP3A in human and rodent brain. Drug Metabol. Rev. 40, 149168.
  • Zastre J. A., Chan G. N. Y., Ronaldson P. T., Ramaswamy M., Couraud P. O., Romero I. A., Weksler B., Bendayan M. and Bendayan R. (2009) Up-regulation of p-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J. Neurosci. Res. 87, 10231036.
  • Zelko I., Sueyoshi T., Kawamoto T., Moore R. and Negishi M. (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol. Cell. Biol. 21, 28382846.